First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)-Reference-Cited by-同舟云学术

First-line single-agent cetuximab in elderly patients with metastatic colorectal cancer. A phase II clinical and molecular study of the Spanish group for digestive tumor therapy (TTD)

Published:2011-01 Issue:1 Volume:77 Page:78-84
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Sastre J.,Aranda E.,Grávalos C.,Massutí B.,Varella-Garcia M.,Rivera F.,Soler G.,Carrato A.,Manzano J.L.,Díaz-Rubio E.,Hidalgo M.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference30 articles.

1. Survival of colorectal cancer patients in Europe during period 1978–1989;Gatta;Eur J Cancer,1998

2. Underrepresentation of patients 65 years of age or older in cancer-treatment trials;Hutchins;N Engl J Med,1999

3. Uracil and tegafur modulated with leucovorin. An effective regimen with low toxicity for the treatment of colorectal carcinoma in the elderly;Feliu;Cancer,1997

4. Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen;Feliu;Eur J Cancer,2002

5. Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer;Abad;Rev Oncol,2000

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Tolerability of First-Line Anti-eGFR and Anti-VEGF Therapy in Elderly Patients with Ras-Wild Metastatic Colon Cancer;Istanbul Medical Journal;2024-08-14

2. Guidance for Treating the Older Adults with Colorectal Cancer;Current Treatment Options in Oncology;2023-04-13

3. An Update on the Role of Anti-EGFR in the Treatment of Older Patients with Metastatic Colorectal Cancer;Journal of Clinical Medicine;2022-11-30

4. Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years;European Journal of Cancer;2022-03

5. Metastatic Colorectal Cancer Outcomes by Age Among ARCAD First- and Second-Line Clinical Trials;JNCI Cancer Spectrum;2022-02-26